Skip to main content
Start triage

Start triage first, then route to emergency care.

Start symptom intake Emergency vets near you

Need urgent help? Start triage first, then route to emergency care.

Start symptom intake Emergency vets near you

Roxee Meds Catalog

Betamethasone

Medication catalog facts with explicit FDA-approval, off-label, source-limited, and safety context.

Both Catalog complete FDA data linked Rx required Injectable Suspension American Regent, Inc. Official label facts Owner quick guide first
Start Symptom Intake Talk to a Vet / Find a Vet Near You

Veterinary professional?

Showing simplified owner view. Switch to Vet View for full technical detail.

Data freshness

Storefront facts
Catalog refreshed
May 2, 2026, 10:05 a.m.

These are the storefront facts Roxee uses on browse cards and quick facts.

FDA applications
FDA application data refreshed
May 5, 2026, 10:00 a.m.

Sponsor, product, and application records imported from Animal Drugs @ FDA.

Safety reports
No safety reports linked
No refresh timestamp yet

openFDA reaction terms and case summaries are supporting evidence, not proof of causality.

Source timing details
Source timing details
  • Storefront facts: Source Roxee | Refreshed May 2, 2026, 10:05 AM UTC
    The storefront fact projection used for browse cards and quick facts.
  • Animal Drugs @ FDA: Source FDA | Refreshed May 5, 2026, 10:00 AM UTC
    Applications/products are imported from FDA export data.
  • Animal Drugs @ FDA previews: Source FDA | Refreshed Feb 9, 2026, 3:05 AM UTC
    Label highlights/doc links are fetched from FDA preview endpoints.
  • Animal Drug Product Listing Directory (NDC): Source FDA | Refreshed May 5, 2026, 10:00 AM UTC
    Package/product NDCs from FDA’s electronic listing directory (XLS).

Evidence

Reviewed / Updated / Sources

Reviewed by: Not available

Last reviewed: April 22, 2026

Updated: April 22, 2026, 10:07 AM UTC

Sources:
Image coming soon
Betamethasone

Betamethasone

Drug type: Generic ingredient • Branded profile • FDA branded products available

Both Injectable Suspension Rx required 100% storefront ready

Species: Both

Manufacturer: American Regent, Inc.

Medication Snapshot

Merged from the current Roxee medication system with field-level provenance, freshness, and completeness tracking.

Betamethasone

It is used or intended for use for the treatment of various inflammatory joint conditions; for example, acute and traumatic lameness involving the carpel and fetlock joints. For treatment of external eye infections and inflammation in dogs. For the treatment of infected superficial lesions caused by bacteria sensitive to gentamicin. Species commonly shown: Both, No Use Class Stated Or Implied, Horse, Not For Meat Production.

Generic name
Betamethasone
Brand names
BetaVet®, Betavet Soluspan Suspension, BetaVet
Manufacturer
American Regent, Inc.
Species
Both, No Use Class Stated Or Implied, Horse, Not For Meat Production
Dosage forms
Injectable Suspension, Liquid (Suspension)
Prescription
Prescription required
Completeness
100%
Validation
Complete
Brand names
BetaVet® Betavet Soluspan Suspension BetaVet
Dosage forms
Injectable Suspension Liquid (Suspension)

Indications / Uses

It is used or intended for use for the treatment of various inflammatory joint conditions; for example, acute and traumatic lameness involving the carpel and fetlock joints. For treatment of external eye infections and inflammation in dogs. For the treatment of infected superficial lesions caused by bacteria sensitive to gentamicin.

Warnings / Contraindications

Not for use in horses intended or food. For use only by or on the order of a licensed veterinarian. Federal law restricts this drug to use by or on the order of a licensed veterinarian. It has been demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

  • Not for use in horses intended or food. For use only by or on the order of a licensed veterinarian. Federal law restricts this drug to use by or on the order of a licensed veterinarian. It has been demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Side Effects

Top reported reactions (openFDA): Lack of efficacy - NOS, Loss of hearing, Ear discharge, Vomiting, Deafness, Hearing decreased.

FAQ

Both, No Use Class Stated Or Implied, Horse, Not For Meat Production

Yes. Roxee shows this as prescription-only.

Injectable Suspension, Liquid (Suspension)

Related Conditions

Lameness (undifferentiated) Osteoarthritis (Degenerative Joint Disease) Osteoarthritis (Degenerative Joint Disease) Pain (acute, chronic) Trauma (HBC, falls, bite wounds)

Source Transparency

Add to My Pet's Meds

Choose a pet, confirm current or past, and optionally add reminder notes.

Sign in to save this medication to your pet profile.

Sign in to continue

Pet Owner Quick Guide

Start here first for the safest next-step summary before the deeper medication detail.

Used for:

For the control of pain and inflammation associated with osteoarthritis in horses.

Dosing note:

Exact dosing depends on your pet's species, weight, and health status. Use your veterinarian's instructions for the exact dose and schedule.

What to watch for:

  • Not for use in horses intended or food
  • For use only by or on the order of a licensed veterinarian
  • It has been demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis
  • wobbly/unsteady walking (1 reports)
  • Head shake - ear disorder (1 reports)
  • Falling (1 reports)

When to call the vet:

  • Repeated vomiting or diarrhea.
  • Severe lethargy (hard to wake, very low energy).
  • Collapse or fainting.
  • Trouble breathing.
  • Facial swelling or hives.
  • Blood in vomit or stool.

Regulatory restrictions are shown in Vet View.

What to tell or ask your vet today:

  • Is this medicine the right fit for my pet’s current symptoms?
  • Which warning signs mean I should call back right away?
  • How should I handle missed doses or refusal to take the medicine?
Major cautions & emergency warning signs

Side effects to monitor:

  • Not for use in horses intended or food
  • For use only by or on the order of a licensed veterinarian
  • It has been demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis
  • wobbly/unsteady walking
  • Head shake - ear disorder

Most reported reactions:

  • Unsteady walking (ataxia) (1 reports)
  • Head shake - ear disorder (1 reports)
  • Falling (1 reports)

Emergency warning signs:

  • Repeated vomiting or diarrhea.
  • Severe lethargy (hard to wake, very low energy).
  • Collapse or fainting.
  • Trouble breathing.
Talk to a Vet / Find a Vet Near You Start Symptom Intake

Quick Facts

Official label facts first, then secondary summaries. Marketing content is separated below.

Species: Both
Manufacturer: American Regent, Inc.
Form: Injectable Suspension, Liquid (Suspension)
Identifiers:
ANADA: 200183 ANADA: 200188 ANADA: 200229 ANADA: 200283 ANADA: 200287 ANADA: 200388 ANADA: 200415 ANADA: 200416 NADA: 113231 NADA: 132338 NADA: 140896 NADA: 141418 NADA: 141437 NADA: 34010 NADA: 34267 NADA: 46821 NADA: 49185 NDC Package: 0061-0100-01 NDC Package: 0061-0387-01 NDC Package: 0061-0387-02
Source metadata:

Warnings / Contraindications

Not for use in horses intended or food. For use only by or on the order of a licensed veterinarian. Federal law restricts this drug to use by or on the order of a licensed veterinarian. It has been demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

  • High: Not for use in horses intended or food. For use only by or on the order of a licensed veterinarian. Federal law restricts this drug to use by or on the order of a licensed veterinarian. It has been demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Source metadata:

Adverse Reactions

Snapshot first, detailed rows second. This section summarizes signal data and is not a diagnosis.

Tap or hover a reaction to see what it means in plain language.

Tracked signals
32
Reported cases
32
Serious reports
13
Species represented
2
Grouped by Body System
Skin & allergy (2) · Hair loss at application site, Application site pruritus Neurologic (1) · Unsteady walking (ataxia) Behavior (1) · Behavioral disorder (unspecified) Other (28) · Head shake - ear disorder, Glucosuria, Falling
Most Reported Reactions
Reaction Body system Cases Species Serious cases
Neurologic 1 Cat 1
Other 1 Dog 1
Other 1 Cat 1
Other 1 Dog 1
Other 1 Dog 1
Other 1 Dog 1
Other 1 Dog 1
Other 1 Dog 1

Species coverage: Cat (18) Dog (14)

View detailed reaction table
Reaction Body system Species Seriousness Frequency Reports
Neurologic Cat Serious - 1
Other Dog Serious - 1
Skin & allergy Cat Non-serious - 1
Other Cat Non-serious - 1
Other Cat Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Other Cat Non-serious - 1
Other Cat Non-serious - 1
Other Cat Non-serious - 1
Other Dog Non-serious - 1
Other Dog Serious - 1
Other Dog Non-serious - 1
Other Dog Non-serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Behavior Dog Serious - 1
Other Cat Non-serious - 1
Other Cat Non-serious - 1
Other Cat Non-serious - 1
Skin & allergy Cat Non-serious - 1
Other Cat Non-serious - 1
Other Cat Non-serious - 1
Other Cat Non-serious - 1
Other Cat Non-serious - 1
Other Cat Non-serious - 1
Other Cat Non-serious - 1
Other Dog Serious - 1
Other Cat Non-serious - 1
Source metadata:

Documents

Owner handouts and official technical documents open on-page first, with the original source still one click away.

Owner handouts

0
No owner handouts linked yet.

Official label / PI

1

SPL

3

FOI

15

N-141418-C-0022-NF-AA_PI.pdf

Official label / PI · Labeling

Open original

BetaVet®

SPL · SPL

Open original
FDA Structured Product Label

BetaVet®

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor
American Regent, Inc.
NADA
141-418
Status
RX
Form
Injectable Suspension
Route
Intra-Articular
Species
No Use Class Stated Or Implied
Composition / specifications
6 mg/mL as 3.15 mg betamethasone sodium phosphate and 2.85 mg betamethasone acetate

Horses

Indication

For the control of pain and inflammation associated with osteoarthritis in horses.

Dosage

Using strict aseptic technique, administer 1.5 mL BetaVet ® (9 mg total betamethasone) per joint by intra-articular injection. BetaVet ® may be administered concurrently in up to 2 joints per horse.

Limitations
Do not use in horses intended for human consumption.

Betavet Soluspan Suspension

SPL · SPL

Open original
FDA Structured Product Label

Betavet Soluspan Suspension

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor
Intervet, Inc.
NADA
34010
Status
RX
Form
Liquid (Suspension)
Route
Intra-Articular
Species
Horse, Not For Meat Production
Composition / specifications
The drug is a sterile aqueous suspension and each cubic centimeter contains: 12 milligrams of betamethasone acetate (equivalent to 10.8 milligrams of betamethasone), 3.9 milligrams of betamethasone disodium phosphate (equivalent to 3 milligrams of betamethasone)

Horses

Indication
It is used or intended for use for the treatment of various inflammatory joint conditions; for example, acute and traumatic lameness involving the carpel and fetlock joints.
Dosage
Administer from 2.5 to 5 cubic centimeters per dose by intra-articular injection. Dose may be repeated when necessary depending upon the duration of relief obtained.
Limitations
Not for use in horses intended or food. For use only by or on the order of a licensed veterinarian.

BetaVet SPL

SPL · Structured Product Label

Open original
FDA Structured Product Label XML for BetaVet. Use the source link for the full official labeling record.

UCM433794.pdf

FOI · FOI

Open original

A200229_Orig_4_4_1998.pdf

FOI · FOI summary

Open original

UCM061643.pdf

FOI · FOI summary

Open original

A200188_Org_1_29_97.pdf

FOI · FOI summary

Open original

A200183_Org_7_31_1995.pdf

FOI · FOI summary

Open original

UCM436650.pdf

FOI · FOI summary

Open original

UCM167677.pdf

FOI · FOI summary

Open original

N140896_Org_6_9_1993.pdf

FOI · FOI summary

Open original

UCM292007.pdf

FOI · FOI summary

Open original

ucm061352.pdf

FOI · FOI summary

Open original

ucm061714.pdf

FOI · FOI summary

Open original

ucm061715.pdf

FOI · FOI summary

Open original

ucm061716.pdf

FOI · FOI summary

Open original

ucm061711.pdf

FOI · FOI summary

Open original

UCM436590.pdf

FOI · FOI summary

Open original
Source metadata:
Veterinary reference (advanced)

Canonical medication sections are above. This legacy block remains available for deeper cross-reference without cluttering the primary workflow.

At a Glance

Quick facts and links to official labeling and safety signals.

Data freshness
  • Storefront facts: Source Roxee | Refreshed May 2, 2026, 10:05 AM UTC
    The storefront fact projection used for browse cards and quick facts.
  • Animal Drugs @ FDA: Source FDA | Refreshed May 5, 2026, 10:00 AM UTC
    Applications/products are imported from FDA export data.
  • Animal Drugs @ FDA previews: Source FDA | Refreshed Feb 9, 2026, 3:05 AM UTC
    Label highlights/doc links are fetched from FDA preview endpoints.
  • Animal Drug Product Listing Directory (NDC): Source FDA | Refreshed May 5, 2026, 10:00 AM UTC
    Package/product NDCs from FDA’s electronic listing directory (XLS).
Official (FDA)
Identity: Generic ingredient • FDA branded products available
Official FDA brands: BetaVet
Manufacturer mapping: American Regent, Inc.
Catalog species: Both • FDA-labeled species: Horse, No Use Class Stated Or Implied
Rx/OTC: RX
Form/route: Injectable Suspension, Liquid (Suspension) • Intra-Articular
Applications: NADA 141-418 • NADA 34010
NDC: Packages 10797-720-01 • Products 10797
Documents: 2 (FOI: 1) • SPL: 2 • Label highlights • Official documents
Safety (openFDA)
Top reactions: Dog 0 • Cat 0 • View
Case summaries: 0
openFDA reports are unverified and do not prove causation.
Explore
Linked using: Fda_Label (0.95), Fda_Label (0.95), Fda_Label (0.95)
Diagnosis Codes
ICD10_CM: H60.90 ICD10_CM: M19.90
Otitis externa, unspecified ear

Counseling and Monitoring Highlights

Global Pet owner/Vet mode is controlled in the header. This section avoids duplicate in-page persona tabs.

Owner-facing counseling points
  • Not for use in horses intended or food. For use only by or on the order of a licensed veterinarian. Federal law restricts this drug to use by or on the order of a licensed veterinarian. It has been demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian. (Contraindication, High)
Top reaction signals
Unsteady walking (ataxia) (1) Head shake - ear disorder (1) Falling (1) Facial paralysis (1) Eye redness (1) Eye irritation (1) Excessive ear wax (1) Ear infection NOS (1)

Identifiers & Packages

Normalized identifiers (NDC/NADA/ANADA) and package metadata from regulator listings.

Identifiers
ANADA: 200183 ANADA: 200188 ANADA: 200229 ANADA: 200283 ANADA: 200287 ANADA: 200388 ANADA: 200415 ANADA: 200416 NADA: 113231 NADA: 132338 NADA: 140896 NADA: 141418 NADA: 141437 NADA: 34010 NADA: 34267 NADA: 46821 NADA: 49185 NDC Package: 0061-0100-01 NDC Package: 0061-0387-01 NDC Package: 0061-0387-02 NDC Package: 0061-0387-03 NDC Package: 0061-0387-08 NDC Package: 0061-0387-17 NDC Package: 10797-720-01
Package NDC Product NDC Form / Route Status
0061-0100-01 0061 -
0061-0387-01 0061 -
0061-0387-02 0061 -
0061-0387-03 0061 -
0061-0387-08 0061 -
0061-0387-17 0061 -
10797-720-01 10797 -
17033-277-02 17033 -
17033-277-20 17033 -
17033-283-02 17033 -
17033-283-20 17033 -

Enriched Documents

Documents are tiered by source trust: Official, Clinical, Manufacturer, Marketing.

  • BetaVet SPL • Structured Product Label • Official
    FDA Structured Product Label from the electronic animal drug product listing directory.
  • A200229_Orig_4_4_1998.pdf • FOI summary • Official • Feb. 27, 2026
    FDA FOI summary for application 200229
  • UCM061643.pdf • FOI summary • Official • Feb. 27, 2026
    FDA FOI summary for application 200229
  • A200188_Org_1_29_97.pdf • FOI summary • Official • Feb. 27, 2026
    FDA FOI summary for application 200188
  • A200183_Org_7_31_1995.pdf • FOI summary • Official • Feb. 27, 2026
    FDA FOI summary for application 200183
  • N-141418-C-0022-NF-AA_PI.pdf • Official label • Official • Oct. 25, 2021
    FDA official labeling for application 141418
  • UCM433794.pdf • FOI summary • Official • Oct. 25, 2021
    FDA FOI summary for application 141418
  • UCM436650.pdf • FOI summary • Official • Aug. 11, 2020
    FDA FOI summary for application 141437
  • UCM167677.pdf • FOI summary • Official • Oct. 1, 2019
    FDA FOI summary for application 200388
  • N140896_Org_6_9_1993.pdf • FOI summary • Official • May 17, 2017
    FDA FOI summary for application 140896
  • UCM292007.pdf • FOI summary • Official • June 1, 2016
    FDA FOI summary for application 200416
  • ucm061352.pdf • FOI summary • Official • June 1, 2016
    FDA FOI summary for application 200415
  • ucm061714.pdf • FOI summary • Official • June 1, 2016
    FDA FOI summary for application 200287
  • ucm061715.pdf • FOI summary • Official • June 1, 2016
    FDA FOI summary for application 200287
  • ucm061716.pdf • FOI summary • Official • June 1, 2016
    FDA FOI summary for application 200287
  • ucm061711.pdf • FOI summary • Official • June 1, 2016
    FDA FOI summary for application 200283
  • UCM436590.pdf • FOI summary • Official • June 1, 2016
    FDA FOI summary for application 34267

Data Sources & Change Log

Every non-trivial field is expected to include provenance and update timestamps.

Official 54 Clinical 8 Manufacturer 0 Marketing 0
Current Field Facts
  • contraindications: Not for use in horses intended or food. For use only by or on the order of a licensed veterinarian. Federal law restricts this drug to use by or on the order o… (Clinical, 2026-04-15)
  • contraindications: Not for use in horses intended or food. For use only by or on the order of a licensed veterinarian. Federal law restricts this drug to use by or on the order o… (Clinical, 2026-04-11)
  • side_effects: Top reported reactions (openFDA): Lack of efficacy - NOS, Loss of hearing, Ear discharge, Vomiting, Deafness, Hearing decreased. (Clinical, 2026-05-02)
  • side_effects: Top reported reactions (openFDA): Lack of efficacy - NOS, Loss of hearing, Ear discharge, Vomiting, Deafness, Hearing decreased. (Clinical, 2026-04-22)
  • side_effects: Top reported reactions (openFDA): Lack of efficacy - NOS, Loss of hearing, Ear discharge, Vomiting, Deafness, Hearing decreased. (Clinical, 2026-04-15)
  • side_effects: Top reported reactions (openFDA): Lack of efficacy - NOS, Loss of hearing, Ear discharge, Vomiting, Deafness, Hearing decreased. (Clinical, 2026-04-11)
  • usage: It is used or intended for use for the treatment of various inflammatory joint conditions; for example, acute and traumatic lameness involving the carpel and f… (Clinical, 2026-04-15)
  • usage: It is used or intended for use for the treatment of various inflammatory joint conditions; for example, acute and traumatic lameness involving the carpel and f… (Clinical, 2026-04-11)
  • contraindications: Not for use in horses intended or food. For use only by or on the order of a licensed veterinarian. Federal law restricts this drug to use by or on the order o… (Official, 2026-05-02)
  • contraindications: Not for use in horses intended or food. For use only by or on the order of a licensed veterinarian. Federal law restricts this drug to use by or on the order o… (Official, 2026-04-30)
  • contraindications: Not for use in horses intended or food. For use only by or on the order of a licensed veterinarian. Federal law restricts this drug to use by or on the order o… (Official, 2026-04-22)
  • contraindications: Not for use in horses intended or food. For use only by or on the order of a licensed veterinarian. Federal law restricts this drug to use by or on the order o… (Official, 2026-02-12)
  • indications: For the control of pain and inflammation associated with osteoarthritis in horses. (Official, 2026-05-05)
  • indications: For the control of pain and inflammation associated with osteoarthritis in horses. (Official, 2026-05-03)
  • indications: For the control of pain and inflammation associated with osteoarthritis in horses. (Official, 2026-05-02)
  • indications: For the control of pain and inflammation associated with osteoarthritis in horses. (Official, 2026-04-29)
  • indications: For the control of pain and inflammation associated with osteoarthritis in horses. (Official, 2026-04-28)
  • indications: For the control of pain and inflammation associated with osteoarthritis in horses. (Official, 2026-04-27)
  • indications: For the control of pain and inflammation associated with osteoarthritis in horses. (Official, 2026-04-26)
  • indications: For the control of pain and inflammation associated with osteoarthritis in horses. (Official, 2026-04-25)
Recent Revisions
  • side_effects updated 2026-05-02 10:05 by etl_backfill • Backfilled from existing medication fields
  • contraindications updated 2026-05-02 10:05 by etl_backfill • Backfilled from existing medication fields
  • usage updated 2026-05-02 10:05 by etl_backfill • Backfilled from existing medication fields
  • side_effects updated 2026-04-30 10:09 by etl_backfill • Backfilled from existing medication fields
  • contraindications updated 2026-04-30 10:09 by etl_backfill • Backfilled from existing medication fields
  • usage updated 2026-04-30 10:09 by etl_backfill • Backfilled from existing medication fields
  • side_effects updated 2026-04-22 10:07 by etl_backfill • Backfilled from existing medication fields
  • contraindications updated 2026-04-22 10:07 by etl_backfill • Backfilled from existing medication fields
  • usage updated 2026-04-22 10:07 by etl_backfill • Backfilled from existing medication fields
  • side_effects updated 2026-04-15 10:04 by etl_backfill • Backfilled from existing medication fields
  • contraindications updated 2026-04-15 10:04 by etl_backfill • Backfilled from existing medication fields
  • usage updated 2026-04-15 10:04 by etl_backfill • Backfilled from existing medication fields
  • side_effects updated 2026-04-11 10:05 by etl_backfill • Backfilled from existing medication fields
  • contraindications updated 2026-04-11 10:05 by etl_backfill • Backfilled from existing medication fields
  • usage updated 2026-04-11 10:05 by etl_backfill • Backfilled from existing medication fields
  • side_effects updated 2026-02-12 22:44 by etl_backfill • Backfilled from existing medication fields
  • contraindications updated 2026-02-12 22:44 by etl_backfill • Backfilled from existing medication fields
  • usage updated 2026-02-12 22:44 by etl_backfill • Backfilled from existing medication fields

FDA Products & Applications (Animal Drugs @ FDA)

Official sponsor/proprietary-name/application-status records linked by active ingredient.

Product Sponsor Application Status Published
BetaVet®
RX
Betamethasone Acetate Betamethasone Sodium Phosphate
Injectable Suspension • Intra-Articular
Label highlights
Official documents
American Regent, Inc. NADA 141-418 Approved Oct 25, 2021
Betavet Soluspan Suspension
RX
Betamethasone Acetate Betamethasone Sodium Phosphate
Liquid (Suspension) • Intra-Articular
Label highlights
Official documents
Intervet, Inc. NADA 34010 Approved Jun 1, 2016

Data source: FDA Animal Drugs @ FDA (public search export).

What It's For (FDA Label Highlights)

Extracted from FDA Animal Drugs @ FDA product labeling. Always confirm details with your veterinarian.

Species: No Use Class Stated Or Implied
Composition / specifications
6 mg/mL as 3.15 mg betamethasone sodium phosphate and 2.85 mg betamethasone acetate
Horses
Indication

For the control of pain and inflammation associated with osteoarthritis in horses.

Dosage

Using strict aseptic technique, administer 1.5 mL BetaVet ® (9 mg total betamethasone) per joint by intra-articular injection. BetaVet ® may be administered concurrently in up to 2 joints per horse.

Limitations
Do not use in horses intended for human consumption.

FDA page: Open in Animal Drugs @ FDA

Species: Horse, Not For Meat Production
Composition / specifications
The drug is a sterile aqueous suspension and each cubic centimeter contains: 12 milligrams of betamethasone acetate (equivalent to 10.8 milligrams of betamethasone), 3.9 milligrams of betamethasone disodium phosphate (equivalent to 3 milligrams of betamethasone)
Horses
Indication
It is used or intended for use for the treatment of various inflammatory joint conditions; for example, acute and traumatic lameness involving the carpel and fetlock joints.
Dosage
Administer from 2.5 to 5 cubic centimeters per dose by intra-articular injection. Dose may be repeated when necessary depending upon the duration of relief obtained.
Limitations
Not for use in horses intended or food. For use only by or on the order of a licensed veterinarian.

FDA page: Open in Animal Drugs @ FDA

Usage

It is used or intended for use for the treatment of various inflammatory joint conditions; for example, acute and traumatic lameness involving the carpel and fetlock joints. For treatment of external eye infections and inflammation in dogs. For the treatment of infected superficial lesions caused by bacteria sensitive to gentamicin.

Source: FDA Animal Drugs @ FDA • Reference

Contraindications

Not for use in horses intended or food. For use only by or on the order of a licensed veterinarian. Federal law restricts this drug to use by or on the order of a licensed veterinarian. It has been demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Top Reported Reactions (openFDA)

De-duplicated reaction terms grouped by body system from FDA openFDA reports (not verified; does not prove causation).

Skin & allergy
Hair loss at application site (1) • Cat Application site pruritus (1) • Cat

Showing top 5 for Skin & allergy.

Neurologic
Unsteady walking (1) • Cat

Showing top 5 for Neurologic.

Behavior
Behavioral disorder (1) • Dog

Showing top 5 for Behavior.

Other
Head shake - ear disorder (1) • Dog Glucosuria (1) • Cat Falling (1) • Cat Facial paralysis (1) • Dog Eye redness (1) • Dog
Show more (23)
Eye irritation (1) • Dog Excessive ear wax (1) • Dog Elevated globulins (1) • Cat Elevated blood urea nitrogen (1) • Cat Elevated alanine aminotransferase (1) • Cat Ear pain (1) • Dog Ear infection NOS (1) • Dog Ear discharge (1) • Dog Ear canal erythema (1) • Dog Drooping eyelid (1) • Dog Depressed ocular reflex (1) • Dog Blinking (1) • Dog Application site ulcer (1) • Cat Application site self trauma (1) • Cat Application site scab (1) • Cat Application site fibrosis (1) • Cat Application site erythema (1) • Cat Application site dermatitis (1) • Cat Application site crust (1) • Cat Application site bleeding (1) • Cat Abscess NOS (1) • Cat Abnormal pupil light reflex (1) • Dog Abnormal cytology (1) • Cat

Showing top 5 for Other.

Data source: FDA openFDA Animal & Veterinary adverse event reports.

Adverse Event Case Summaries (openFDA)

These are individual FDA adverse event reports. They are unverified and do not prove the medication caused the reaction.

No case-level openFDA reports are linked for this medication yet.

Data source: FDA openFDA Animal & Veterinary adverse event reports.

Overdose Information

No approved overdose-management text is linked yet. If overdose is suspected, contact a veterinarian or emergency clinic immediately.

Storage & Handling

No approved storage guidance is linked yet for this ingredient. Use manufacturer packaging and veterinary guidance for handling/storage.

Share Your Thoughts

Let others know your experience or advice regarding this medication.

This medication has not been reviewed by a veterinarian yet.